Table 2.

Potency of 5-HT with or without inhibition of Rho-kinase by Y-27632 in thoracic aorta of WT or SMG4 mice treated with angiotensin II (AngII)

	E max_5-HT
	WT-AngII	SMG4-AngII
Control	162.3 ± 8.27	122.4 ± 3.38
1 µmol/L Y-27632	94.78 ± 5.17	75.56 ± 3.73
10 µmol/L Y-27632	42.32 ± 1.42	33.66 ± 1.71

Values are mean ± SE; n ≥ 15.